Search by Drug Name or NDC

    NDC 00115-1526-08 Lamotrigine 25 mg/1 Details

    Lamotrigine 25 mg/1

    Lamotrigine is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals of New York LLC. The primary component is LAMOTRIGINE.

    Product Information

    NDC 00115-1526
    Product ID 0115-1526_9611e358-6fe1-4f8d-99a2-250a7862a896
    Associated GPIs 72600040007225
    GCN Sequence Number 065167
    GCN Sequence Number Description lamotrigine TAB RAPDIS 25 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 23201
    HICL Sequence Number 007378
    HICL Sequence Number Description LAMOTRIGINE
    Brand/Generic Generic
    Proprietary Name Lamotrigine
    Proprietary Name Suffix n/a
    Non-Proprietary Name LAMOTRIGINE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, ORALLY DISINTEGRATING
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units mg/1
    Substance Name LAMOTRIGINE
    Labeler Name Amneal Pharmaceuticals of New York LLC
    Pharmaceutical Class Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA200828
    Listing Certified Through 2024-12-31

    Package

    NDC 00115-1526-08 (00115152608)

    NDC Package Code 0115-1526-08
    Billing NDC 00115152608
    Package 2 BLISTER PACK in 1 CARTON (0115-1526-08) / 15 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (0115-1526-68)
    Marketing Start Date 2015-01-09
    NDC Exclude Flag N
    Pricing Information N/A